Specialty chemicals and nutritional ingredients company Cognis announced this week that it has signed a Memorandum of Understanding with Norwegian research and development company, Natural ASA.
The agreement grants Cognis an exclusive license to Natural's Conjugated Linoleic Acid (CLA) IP knowledge and trademarks.
Under terms of the agreement Cognis will have the rights to the worldwide marketing and manufacturing of Natural's products and technology for dietary supplements, functional food, personal care, and pharmaceuticals.
Paul Allen, head of the Nutrition & Health business at Cognis said: "Dietary supplements and functional foods are two of the key market segments of Cognis' designated growth business unit, Nutrition & Health."
"Building on the scientific work of Natural ASA, Cognis will be able to considerably grow the market for CLA through the talents of our worldwide sales and marketing organisation, as well as through our know-how in oleochemistry."
The final agreement between the two companies is expected by July 2002.
